Global Opioid Induced Constipation Market Share

Market Share of Global Opioid Induced Constipation Industry

The Opioid Induced Constipation market is moderately competitive and consists of several major players. Some of the companies are expanding their market position by adopting various strategies such as acquisitions and mergers, while others are developing new methods for the treatment and introducing new products to maintain their market share. A few of the major players currently dominating the industry in terms of revenue are AstraZeneca plc, Mallinckrodt Pharmaceuticals, Bausch Health (Salix Pharmaceuticals Inc), Merck & Co Inc, and Shionogi & Co Ltd.

Opioid Induced Constipation (OIC) Market Leaders

1. AstraZeneca plc

2. Merck & Co Inc

3. Shionogi & Co Ltd

4. Mallinckrodt Pharmaceuticals

5. Bausch Health ( Salix Pharmaceutical Inc.)

*Disclaimer: Major Players sorted in no particular order